Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Molecular Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1385/JMN:23:3:225PMID 15181251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

  2003cited by this paper
• HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

  2003cited by this paper
• Statin therapy for Alzheimer’s disease

  2002cited by this paper
• Functional Characterization of the 5′‐Regulatory Region of the Murine Apolipoprotein Gene

  2002cited by this paper
• Strategies for drug discovery for cognitive aging and alzheimer’s disease

  2002cited by this paper
• Statin therapy for Alzheimer's disease: will it work?

  2002cited by this paper
• Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain

  2001cited by this paper
• High Expression of Apolipoprotein E mRNA in the Brains with Sporadic Alzheimer’s Disease

  2001cited by this paper
• Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.

  2001cited by this paper
• LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.

  2001cited by this paper
• Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E.

  2000cited by this paper
• Duplicated Downstream Enhancers Control Expression of the Human Apolipoprotein E Gene in Macrophages and Adipose Tissue*

  2000cited by this paper
• Analysis of the 5'-flanking region of the beta-amyloid precursor protein gene that contributes to increased promoter activity in differentiated neuronal cells.

  2000cited by this paper
• Neuroinflammation and Alzheimer's disease: Critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E

  2000cited by this paper
• The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.

  2000cited by this paper
• Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element.

  1999cited by this paper
• Apolipoprotein E expression by neurons surviving excitotoxic stress.

  1999cited by this paper
• Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE.

  1999cited by this paper
• Specific regional transcription of apolipoprotein E in human brain neurons.

  1999cited by this paper
• Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning.

  1998cited by this paper
• Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein

  1998cited by this paper
• Molecular cloning of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein: structural characterization and a comparative study with other species.

  1998cited by this paper
• Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

  1998cited by this paper
• Functional identification of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein.

  1998cited by this paper
• Human apolipoprotein E: the Alzheimer's disease connection

  1996cited by this paper
• Transcription Factor AP-2 Regulates Human Apolipoprotein E Gene Expression in Astrocytoma Cells

  1996cited by this paper
• Apolipoprotein E alleles as risk factors in Alzheimer's disease.

  1996cited by this paper
• Characterization of an upstream regulatory sequence and its binding protein in the mouse apolipoprotein E gene.

  1995cited by this paper
• Novel Sequence Determinants in Peroxisome Proliferator Signaling (*)

  1995cited by this paper
• Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

  1995cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Structure and expression of mouse apolipoprotein E gene.

  1989cited by this paper
• Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

  1987cited by this paper
• Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets.

  1985cited by this paper
• Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit.

  1985cited by this paper

• APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial

  2024cites this paper
• The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms

  2024cites this paper
• Targeting Oligodendrocyte Dynamics and Remyelination: Emerging Therapies and Personalized Approaches in Multiple Sclerosis Management.

  2024cites this paper
• Mitochondria Profoundly Influence Apolipoprotein E Biology

  2023cites this paper
• Irisin reduces amyloid-b by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling

  2023cites this paper
• Mediator complex in neurological disease

  2023cites this paper
• Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer’s drugs

  2023cites this paper
• Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly

  2022cites this paper
• APOE polymorphism status (E4) may help in predicting the risk of recurrent implantation failure

  2021cites this paper
• Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis

  2021cites this paper
• Genetic and regulatory architecture of Alzheimer's disease in the APOE region

  2020cites this paper
• Prenatal NO2 exposure and neurodevelopmental disorders in offspring mice: Transcriptomics reveals sex-dependent changes in cerebral gene expression.

  2020cites this paper
• Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction

  2020cites this paper
• Cholesterol and Dementia: A Long and Complicated Relationship

  2020cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Cholesterin – Baustein oder Risikofaktor?

  2019cites this paper
• Cellular Specificity of NF-κB Function in the Nervous System

  2019cites this paper
• Cholesterin – Baustein oder Risikofaktor?

  2019cites this paper
• Effect of Low-Dose Statins and Apolipoprotein E Genotype on Cerebral Small Vessel Disease in Older Hypertensive Patients: A Subgroup Analysis of a Randomized Clinical Trial.

  2018cites this paper
• Genetic Architecture of the Cardiovascular Risk Proteome

  2017cites this paper
• Cholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions

  2017cites this paper
• Homocysteine metabolism and the associations of global DNA methylation with selected gene polymorphisms and nutritional factors in patients with dementia.

  2016cites this paper
• Bio-behavioral inquiries regarding cognitive aging and distance to death: The role of gender, APOE, grip strength and subjective memory

  2016cites this paper
• Cholesterol overload impairing cerebellar function: the promise of natural products.

  2015cites this paper
• Chandipura virus perturbs cholesterol homeostasis leading to neuronal apoptosis

  2015cites this paper
• Cholesterol metabolism and homeostasis in the brain

  2015influential citation
• Role of walnuts in maintaining brain health with age.

  2014cites this paper
• – What Comes First : The Food or the Nutrient ? Role ofWalnuts inMaintaining Brain Healthwith Age 1 – 3

  2014cites this paper
• Proteomic profiling of the phosphoproteins in the rat thalamus, hippocampus and frontal lobe after propofol anesthesia

  2014cites this paper
• A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms

  2014cites this paper
• Functional Role of Walnuts and Açaí Fruits on Brain Health

  2013cites this paper
• Signaling pathways of apoE and its role of gene expression in glomerulus diseases

  2013influential citation
• Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress.

  2012cites this paper
• Cholesterol: Its Regulation and Role in Central Nervous System Disorders

  2012influential citation
• The “LEARn” (Latent Early-Life Associated Regulation) Model: An Epigenetic Pathway Linking Metabolic and Cognitive Disorders

  2012cites this paper
• AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes.

  2012cites this paper
• Redox proteomics and drug development.

  2011cites this paper
• Association of apolipoprotein E polymorphisms with cerebral vasospasm after spontaneous subarachnoid hemorrhage.

  2011cites this paper
• Association of promoter polymorphism of apolipoprotein E gene with cerebral vasospasm after spontaneous SAH.

  2010cites this paper
• The vascular contribution to Alzheimer's disease.

  2010cites this paper
• Association of Apolipoproteins E4 and C1 With Onset Age and Memory: A Study of Sporadic Alzheimer Disease in Taiwan

  2010cites this paper
• Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.

  2010cites this paper
• Apolipoproteins in the brain: implications for neurological and psychiatric disorders

  2010cites this paper
• Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

  2010cites this paper
• Genomics of Brain Aging: Apolipoprotein E

  2009cites this paper
• Functional characterization of three single‐nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA–protein interactions

  2009cites this paper
• APOE-related mortality: effect of dementia, cardiovascular disease and gender.

  2009cites this paper
• Will "personalized medicine" need personalized laboratory approach?

  2009cites this paper
• Genetics of Alzheimer's disease: recent advances

  2009cites this paper
• Ceramide Is Responsible for the Failure of Compensatory Nerve Sprouting in Apolipoprotein E Knock-Out Mice

  2008cites this paper
• Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.

  2007cites this paper
• Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics.

  2007cites this paper
• Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.

  2007cites this paper
• Facteurs de risque et facteurs protecteurs des démences

  2007cites this paper
• [Risk factors and protective factors of the insanities].

  2007cites this paper
• Genetic heterogeneity of Alzheimer's disease: complexity and advances.

  2007cites this paper
• Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study

  2006cites this paper
• Immediate Early Genes, Inducible Transcription Factors and Stress Kinases in Alzheimer's Disease

  2006cites this paper
• Age-related Alterations of Apolipoprotein E and Interleukin-1β in the Aging Brain

  2006cites this paper
• Association Analysis of Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Late Onset Alzheimer’s Disease in the Finnish Population

  2006cites this paper
• Proteomic and Biochemical Analysis of Purified Human Immunodeficiency Virus Type 1 Produced from Infected Monocyte-Derived Macrophages

  2006cites this paper
• Biological Markers of Age-Related Memory Deficits

  2006cites this paper
• Apolipoprotein E Modulates Establishment of HSV-1 Latency and Survival in a Mouse Ocular Model

  2006cites this paper
• Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease

  2006cites this paper
• Single cell gene expression profiling in Alzheimer’s disease

  2006cites this paper
• Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain.

  2006cites this paper
• Statins of Different Brain Penetrability Differentially Affect CSF PLTP Activity

  2006cites this paper
• Effec ts of hyperoxia in alzheimers transgenic mice

  2005cites this paper
• NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells.

  2005cites this paper
• NF-κB mediates amyloid β peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells

  2005cites this paper
• Neuroanatomy/pathology and the interplay of neurotransmitters in moderate to severe Alzheimer disease

  2005cites this paper
• Lethal weapon: amyloid beta-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease.

  2004cites this paper
• Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.

  2004cites this paper
• Acta Universitatis Upsaliensis Uppsala 2016

  year unknowncites this paper